Big-name academic centers round up $20M to dig into ALS data

Johns Hopkins University, Cedars-Sinai and Massachusetts General Hospital have raised $20 million to fuel a research initiative to understand the cause of amyotrophic lateral sclerosis (ALS). The allies plan to use the cash to amass and analyze a trove of clinical, chemical, genetic, protein, historical and biological data from people with ALS. By digging into the data set--which the partners claim will be the largest and most comprehensive of its kind--the collaborators hope to spot what causes ALS and identify targets that could lead to drugs that bring the disease under control. Release

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.